Aifa has ordered withdrawal from the pharmacy and distribution chain of certain batches of the anti-cure drug with ranitidine due to carcinogenic contaminants, precisely due to the presence of an impurity called N-nitrosodimethylamine belonging to the class of nitrosamines contained in the active principle of ranitin .
We see the properties and batches of the drug that are withdrawn and are the subject of warning
Following notices of voluntary withdrawal by the Laboratory Guidotti Spa company, here are the batches of the drug subject for the alert:
1) ULCEX 150 mg cpr AIC 025084017, lot number 162 expiring 11-2019
2) ULCEX 150 mg cpr AIC 025084017, lot number 186 expires 06-2021
3) ULCEX 150 mg cpr AIC 025084017, lot number 186 / A with expiration date 06 -2021
4) ULCEX 300 mg cpr AIC 025084056, lot number 171 expires 05-2020
5) ULCEX 300 mg cpr AIC 025084056, lot number 171 / A expires 05-2020
The runit idina is a acid secretion inhibitors used in the treatment of ulcers, gastroesophageal reflux, heartburn. It should not create problems if consumed in low amounts, but if consumed in excessive amounts, from animal studies, it is probably classified as carcinogenic. It is found in some foods and in water.
We recommend that my consumers, for greater peace of mind, check if they have the lots listed and give rise to warning, just go to the pharmacy and get them replaced with drugs that do not belong to much of the warning.
Not even a month ago ranitidine had a major shock throughout Europe for drugs manufactured in factories in India, so it had been a general warning to trigger a check of all drugs for possible presence of nitrosamines
High blood pressure medicines withdrawn from pharmacy sales: here's the lot
To keep you updated, follow us on: Facebook – Twitter – Gnews – Telegram – Instragram – Pinterest – Youtube – contact us on WhatsApp at the new number 3516559380 – enter this phone book number and send us the following message via WhatsApp: "news", we will respond as soon as possible.